Top headlines: Evergrande threat hits markets; Pfizer vaccine works on kids

Business Standard brings you the top headlines on Monday

pfizer vaccine
BS Web Team New Delhi
2 min read Last Updated : Sep 20 2021 | 6:15 PM IST
World shares at one-month low, default fears stalk China Evergrande

World shares skidded and the dollar firmed on Monday ahead of a week packed with global central bank meetings, while debt troubles at property group China Evergrande dragged Hong Kong stocks towards to a one-year low.

European stocks were 1.8% lower, slipping to two-month lows, with energy and mining stocks tumbling as the dollar's jump to near four-week highs crushed commodity prices. Read more

Pfizer vaccine safe for children aged 5-11, show clinical trial results

Pfizer said Monday its COVID-19 vaccine works for children ages 5 to 11 and that it will seek US authorisation for this age group soon -- a key step toward beginning vaccinations for youngsters.

The vaccine made by Pfizer and its German partner BioNTech already is available for anyone 12 and older. Read more

India to resume export of surplus Covid vaccines from next month: Mandaviya

India will resume export of surplus COVID-19 vaccines next month under the 'Vaccine Maitri' programme and to meet its commitment to the COVAX global pool, but vaccinating its own citizens remains the topmost priority of the government, Health Minister Mansukh Mandaviya said on Monday.

Addressing the media, the minister said the government will receive over 300 millon doses of COVID-19 vaccines in October and over 1 billion doses in the next three months. Read more

HDFC Bank ties up with Paytm to issue co-branded credit cards from Oct

HDFC Bank will work with Paytm to offer co-branded credit cards on the Visa platform to businesspersons, millennials and others, said the lender on Monday.

This tie-up will see the lender leverage its position as the leading credit card-issuer and its expertise in superior customer engagement to offer services to Paytm’s large customer base of 330 million, thus enabling a deeper penetration in Tier II and III cities, accelerating the adoption of digital payments. Read more

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :HDFC BankPfizerCoronavirus Vaccine

Next Story